Evidence map›Paper›PMID 35667377›Full record

ArticleRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia2022

Behavior of the Genetic Markers at Screening during the First Trimester of Pregnancy in Euploid Fetuses.

Ximena Carolina Romero Infante, Montserrat Uriel, Alejandra Gutiérrez, María Fernanda Hernández, Andres Felipe Hernández, Laura Catalina Jiménez, Jeadran Nevardo Malagón-Rojas, Sara Rincón Franco

Abstract read
In one paragraph

Article in Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ximena Carolina Romero InfanteUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Ecodiagnóstico El Bosque SAS, Los Cobos Medical Center, Bogotá, Colombia.ORCID 0000-0002-7040-2705
Montserrat UrielUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Ecodiagnóstico El Bosque SAS, Los Cobos Medical Center, Bogotá, Colombia.ORCID 0000-0001-5987-8633
Alejandra GutiérrezUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Bogotá, Colombia.ORCID 0000-0002-6213-5846
María Fernanda HernándezUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Bogotá, Colombia.ORCID 0000-0002-5976-8597
Andres Felipe HernándezUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Bogotá, Colombia.ORCID 0000-0002-3442-8748
Laura Catalina JiménezUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Bogotá, Colombia.ORCID 0000-0002-9362-5450
Jeadran Nevardo Malagón-RojasUniversidad El Bosque, Research Group of Community Medicine and Collective Health, Bogotá, Colombia.ORCID 0000-0001-5801-936X
Sara Rincón FrancoUniversidad El Bosque, El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Ecodiagnóstico El Bosque SAS, Bogotá, Colombia.ORCID 0000-0002-4594-9151

Funding

PCI-2013-472 Universidad El BosquePMMFGEB-011 El Bosque Research Group of Maternal Fetal Medicine and Gynecology, Ecodiagnóstico El Bosque S. A. S
6 · The paper itself

Abstract

objectiveThis study aims to describe the behavior of chromosomopathy screenings in euploid fetuses.

methodsThis is a prospective descriptive study with 566 patients at 11 to 14 weeks of gestation. The associations between ultrasound scans and serological variables were studied. For the quantitative variables we used the Spearman test; for the qualitative with quantitative variables the of Mann-Whitney U-test; and for qualitative variables, the X

resultsWe have found that gestational age has correlation with ductus venosus, nuchal translucency, free fraction of β subunit of human chorionic gonadotropin, pregnancy-associated plasma protein-A and placental growth factor; there is also a correlation between history of miscarriages and nasal bone. Furthermore, we correlated body mass index with nuchal translucency, free fraction of β subunit of human chorionic gonadotropin, and pregnancy-associated plasma protein-A. Maternal age was associated with free fraction of β subunit of human chorionic gonadotropin and pregnancy-associated plasma protein-A.

conclusionOur study demonstrates for the first time the behavior of the biochemical and ultrasonographic markers of chromosomopathy screenings during the first trimester in euploid fetuses in Colombia. Our information is consistent with international reference values. Moreover, we have shown the correlation of different variables with maternal characteristics to determine the variables that could help with development of a screening process during the first trimester with high detection rates.

Indexed as

Chromosome DisordersDown SyndromeBiomarkersChorionic GonadotropinChorionic Gonadotropin, beta Subunit, HumanFemaleFetusGenetic MarkersHumansMaternal AgeNuchal Translucency MeasurementPlacenta Growth FactorPregnancyPregnancy-Associated Plasma Protein-APregnancy Trimester, FirstPrenatal DiagnosisBiomarkersChorionic GonadotropinChorionic Gonadotropin, beta Subunit, HumanGenetic MarkersPlacenta Growth FactorPregnancy-Associated Plasma Protein-A

Identifiers

PMID35667377
PMCPMC9948148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.